NDC 63833-829

NDC codes

FDA NDC Directory

Product NDC (as listed)63833-829Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63833-0829Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63833-829-02	63833082902	1 KIT in 1 CARTON (63833-829-02) * 5.6 mL in 1 VIAL, SINGLE-USE (63833-839-01) * 5.6 mL in 1 VIAL, SINGLE-USE (63833-765-19)Marketed from Jun 22, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)Suffix: C1 Esterase Inhibitor Subcutaneous (Human)
Generic name (nonproprietary): human c1-esterase inhibitor
Dosage form: Kit
Labeler: CSL Behring GmbH
Product type: Plasma derivative
Marketing category: BLA — Biologics License ApplicationApplication BLA 125606
Marketing start: Jun 22, 2017
Listing expires: Dec 31, 2026
Identifiers: Product ID 63833-829_c53fd34d-f366-4ee5-bbea-88201bf6b7c8SPL ID c53fd34d-f366-4ee5-bbea-88201bf6b7c8

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N463833082902 followed by a unit qualifier and the quantity

Package 63833-0829-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 125606

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 125606
Product	Strength	Form · route	Labeler	Product NDC
HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)human c1-esterase inhibitor	—	Kit	CSL Behring GmbH	63833-828

HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) NDC 63833-829